La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Portman Ridge Finance a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Portman Ridge Finance..

Portman Ridge Finance (NASDAQ:PTMN) Azioni, Catena delle Opzioni

Portman Ridge Finance

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

Portman Ridge Finance Corporation - Closed End Fund

Portman Ridge Finance Corp

<a href="http://abvcpharma.com/">ABVC BioPharma, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced that the Japan Patent Office has granted a new patent protection for its Major Depressive Disorder (MDD) candidate, ABV-1504. The patent, valid through 2040, strengthens ABVC's global intellectual property portfolio for PDC-1421, the active botanical ingredient in ABV-1504. The compound is now protected in four major territories as shown below:
&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Country</td>
<td>Patent Number / Application No.</td>
<td>Status</td>
<td>Valid Through</td>
</tr>
<tr>
<td>United States</td>
<td>US 11,554,154 B2</td>
<td>Granted</td>
<td>2041</td>
</tr>
<tr>
<td>Australia</td>
<td>2021314052</td>
<td>Granted</td>
<td>2041</td>
</tr>
<tr>
<td>Taiwan</td>
<td>109130285</td>
<td>Granted</td>
<td>2040</td>
</tr>
<tr>
<td>Japan</td>
<td>特願2023-502736</td>
<td>Granted</td>
<td>2041</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
This comprehensive patent coverage reinforces ABVC's international strategy to ultimately commercialize its botanical CNS pipeline in the most strategically important pharmaceutical markets.
Botanical Science Meets Global Market Demand
With MDD affecting over 280 million people worldwide and the global antidepressant market projected to reach $20 billion by 2030<a href="https://admin.newmediawire.com/static/xml/releases.xml#_ftn1">[1]</a>, ABV-1504 offers a differentiated, botanical-based alternative to traditional selective serotonin reuptake inhibitors (SSRIs). Derived from Polygala tenuifolia, the compound acts as a Norepinephrine Transporter (NET) inhibitor and has demonstrated favorable safety and efficacy in Phase II clinical studies<a href="https://admin.newmediawire.com/static/xml/releases.xml#_ftn2">[2]</a>. ABV-1504 aims to provide a safer, non-addictive, and better-tolerated long-term treatment for individuals suffering from depression.

Biotech

News

Global

General

ABVC

'ABVC BioPharma Secures Japanese Patent For Its Natural MDD Treatment Candidate ABV-1504'

JMP Securities analyst Jordan Bender maintains Inspired Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSE#NASDAQ">INSE</a>) with a Market Outperform and lowers the price target from $13 to $12.

Price Target

Analyst Ratings

INSE

JMP Securities Maintains Market Outperform on Inspired Entertainment, Lowers Price Target to $12

Eastman Kodak Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) shares dropped 16% to $5.62 on Friday following a weaker-than-expected first-quarter earnings report.
What To Know: The company <a href="https://www.benzinga.com/pressreleases/25/05/b45300118/kodak-reports-first-quarter-2025-financial-results">posted</a> a net loss of $7 million, or a loss of 12 cents per share, a sharp reversal from net income of $32 million, or 30 cents per share, in the same period last year. 
Revenue came in at $247 million, down slightly from $249 million a year ago. Operational EBITDA fell 50% to $2 million, primarily due to rising aluminum and manufacturing costs.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/05/45317301/5-treasury-yields-could-force-trump-to-slash-tariffs-in-q2-says-bofas-hartnett">5% Treasury Yields Could Force Trump To Slash Tariffs In Q2, Says BofA&#8217;s Hartnett</a>
Gross profit declined 6% year-over-year to $46 million, and cash flow from operations saw a $55 million drop. Kodak ended the quarter with $158 million in cash, down from $201 million at the end of 2024, driven by ongoing investments in technology, infrastructure, and its Advanced Materials &amp; Chemicals business.
Despite the financial setbacks, Kodak leadership <a href="https://www.benzinga.com/pressreleases/25/05/b45300118/kodak-reports-first-quarter-2025-financial-results">emphasized</a> its long-term strategy, including U.S.-based manufacturing expansions and the development of FDA-regulated pharmaceutical components. 
CEO Jim Continenza said the company remains focused on streamlining operations and building future growth amid a challenging business environment.
Read Also: <a href="https://www.benzinga.com/25/05/45319531/cathie-wood">Cathie Wood Says AI Will &#8216;Disrupt The Traditional World Order&#8217; And Replace Search Engines Like Google</a>
<h2 class="wp-block-heading">How To Buy KODK Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Eastman Kodak&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KODK has a 52-week high of $8.24 and a 52-week low of $4.26.

KODK

Kodak (KODK) Stock Falls 16% After Disappointing Q1 Earnings

Newsmax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMAX#NYSE">NMAX</a>) saw its shares rise on Friday after the conservative news organization inked a multi-year deal to launch its cable channel <a href="https://www.benzinga.com/general/entertainment/24/10/41443702/disney-and-hulu-stream-away-from-apples-30-toll-bridge-what-it-means-for-the-iphone-maker">on Hulu + Live TV</a>.
The addition marks a pivotal milestone for the network, as Newsmax now holds carriage agreements with every leading pay-TV operator in the country.
Newsmax expects the rollout to expand its reach to roughly 60 million U.S. households beginning in July.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/44850662/as-maga-yall-etfs-gain-traction-trump-media-unveils-values-based-investment-accounts" rel="noreferrer noopener">As MAGA, YALL ETFs Gain Traction, Trump Media Unveils &#8216;Values-Based&#8217; Investment Accounts</a>
The platform expansion is expected to amplify its influence among conservative audiences, particularly those increasingly turning to streaming platforms for news content.
The network began trading publicly on March 31, debuting on the New York Stock Exchange<a href="https://www.benzinga.com/25/03/44577330/newsmax-begins-nyse-trading-as-nmax-ceo-ruddys-net-worth-hits-33-billion" target="_blank" rel="noreferrer noopener"> at a 40% premium to its $10 IPO price</a>.
In a striking start, its shares soared by over 2,200% within just two days. Despite a recent dip of more than 32% over the past month, investor enthusiasm around the <a target="_blank" href="https://www.benzinga.com/general/entertainment/25/04/44600008/2200-in-2-days-newsmax-and-the-curious-case-of-maga-media-on-wall-street" rel="noreferrer noopener">brand&#8217;s growth story remains evident.</a>
Newsmax stated that it will notify shareholders, viewers, and the public once the Hulu + Live TV channel goes live later this summer.
Price Action: NMAX shares are trading higher by 2.1% to $24.09 at last check Friday. 
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45311562/mohamed-el-erian-flags-adverse-implications-for-domestic-industries-as-chinas-exports-rise-8-despite-21-drop-in-us-shipments" target="_blank" rel="noreferrer noopener">Mohamed El-Erian Flags &#8216;Adverse Implications&#8217; For Domestic Industries As China&#8217;s Exports Rise 8% Despite 21% Drop In US Shipments</a></li>
</ul>

Equities

Markets

Movers

NMAX

What's Going On With Newsmax Stock Today?

Lake Street analyst Jacob Stephan maintains PaySign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYS#NASDAQ">PAYS</a>) with a Buy and raises the price target from $6 to $7.

PAYS

Lake Street Maintains Buy on PaySign, Raises Price Target to $7

SelectQuote (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) is preparing to release its quarterly earnings on Monday, 2025-05-12. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect SelectQuote to report an earnings per share (EPS) of $0.00.
Anticipation surrounds SelectQuote's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.20, leading to a 30.82% increase in the share price on the subsequent day.
Here's a look at SelectQuote's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.1</td>
<td>-0.18</td>
<td>-0.15</td>
<td>0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.3</td>
<td>-0.26</td>
<td>-0.18</td>
<td>0.05</td>
</tr>
<tr>
<td>Price Change %</td>
<td>31.0%</td>
<td>7.000000000000001%</td>
<td>-44.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746802963_0.png" alt="eps graph" />
<h3>SelectQuote Share Price Analysis</h3>
Shares of SelectQuote were trading at $2.73 as of May 08. Over the last 52-week period, shares are down 4.11%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SLQT/earnings">To track all earnings releases for SelectQuote visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

SLQT

Earnings Preview For SelectQuote

Aurinia Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUPH#NASDAQ">AUPH</a>) will release its quarterly earnings report on Monday, 2025-05-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Aurinia Pharmaceuticals to report an earnings per share (EPS) of $0.10.
The announcement from Aurinia Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.03, leading to a 5.3% increase in the share price the following trading session.
Here's a look at Aurinia Pharmaceuticals's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>0.01</td>
<td>0.01</td>
<td>-0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.01</td>
<td>0.10</td>
<td>0.01</td>
<td>-0.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746802954_0.png" alt="eps graph" />
<h3>Market Performance of Aurinia Pharmaceuticals's Stock</h3>
Shares of Aurinia Pharmaceuticals were trading at $8.11 as of May 08. Over the last 52-week period, shares are up 61.25%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/AUPH/earnings">To track all earnings releases for Aurinia Pharmaceuticals visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUPH

Uncovering Potential: Aurinia Pharmaceuticals's Earnings Preview

On May 8, a recent SEC filing unveiled that JAMES FUNK, Director at Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) made an insider sell.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000315852/000112760225013692//Archives/edgar/data/315852/000112760225013692/0001127602-25-013692-index.htm">U.S. Securities and Exchange Commission</a> on Thursday outlined that FUNK executed a sale of 13,582 shares of Range Resources with a total value of $475,777.
Range Resources's shares are actively trading at $36.98, experiencing a up of 0.68% during Friday's morning session.
<h3>Discovering Range Resources: A Closer Look</h3>
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.
<h3>Financial Milestones: Range Resources's Journey</h3>
Revenue Growth: Range Resources's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 42.04%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 43.26%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Range Resources's EPS is below the industry average. The company faced challenges with a current EPS of 0.4. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: Range Resources's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.46.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 33.09, Range Resources's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 3.43 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 14.03 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000315852">Check Out The Full List Of Range Resources's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

Sell Alert: JAMES FUNK Cashes Out $475K In Range Resources Stock

A new SEC filing reveals that JAMES BENNETT, Board Member at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>), made a notable insider purchase on May 8,.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004861//Archives/edgar/data/715957/000122520825004861/0001225208-25-004861-index.htm">U.S. Securities and Exchange Commission</a> on Thursday unveiled that BENNETT made a notable purchase of 3,246 shares of Dominion Energy, valuing at $177,491.
At Friday morning, Dominion Energy shares are up by 0.13%, trading at $55.07.
<h3>About Dominion Energy</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Dominion Energy: Delving into Financials</h3>
Revenue Growth: Over the 3 months period, Dominion Energy showcased positive performance, achieving a revenue growth rate of 12.22% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Utilities sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 50.54%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS is below the industry average. The company faced challenges with a current EPS of 0.75. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.67, Dominion Energy faces challenges in effectively managing its debt levels, indicating potential financial strain.
Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 21.24 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 3.11 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Dominion Energy's EV/EBITDA ratio stands at 12.94, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Cracking Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JAMES BENNETT Takes a Bullish Stance: Acquires $177K In Dominion Energy Stock

OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) is gearing up to announce its quarterly earnings on Monday, 2025-05-12. Here's a quick overview of what investors should know before the release.
Analysts are estimating that OrganiGram Holdings will report an earnings per share (EPS) of $-0.03.
Anticipation surrounds OrganiGram Holdings's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS missed by $0.11, leading to a 6.25% drop in the share price on the subsequent day.
Here's a look at OrganiGram Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.03</td>
<td>-0.03</td>
<td>-0.05</td>
<td>-0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.14</td>
<td>-0.08</td>
<td>0.02</td>
<td>-0.22</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>-1.0%</td>
<td>5.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746802945_0.png" alt="eps graph" />
<h3>Market Performance of OrganiGram Holdings's Stock</h3>
Shares of OrganiGram Holdings were trading at $1.11 as of May 08. Over the last 52-week period, shares are down 38.86%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/OGI/earnings">To track all earnings releases for OrganiGram Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: OrganiGram Holdings's Quarterly Earnings

On May 8, Paul Dabbar, Director at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004862//Archives/edgar/data/715957/000122520825004862/0001225208-25-004862-index.htm">U.S. Securities and Exchange Commission</a> on Thursday unveiled that Dabbar made a notable purchase of 3,246 shares of Dominion Energy, valuing at $177,491.
The latest market snapshot at Friday morning reveals Dominion Energy shares up by 0.13%, trading at $55.07.
<h3>All You Need to Know About Dominion Energy</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Dominion Energy's Financial Performance</h3>
Revenue Growth: Over the 3 months period, Dominion Energy showcased positive performance, achieving a revenue growth rate of 12.22% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Utilities sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 50.54%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.75.
</li>
</ul>
Debt Management: Dominion Energy's debt-to-equity ratio stands notably higher than the industry average, reaching 1.67. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 21.24 suggests caution, as the stock may be overvalued in the eyes of investors.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 3.11, Dominion Energy's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 12.94, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Director At Dominion Energy Buys $177K of Stock

MAYBANK HAGOOD, Board Member at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>), reported an insider buy on May 8, according to a new SEC filing. 
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004863//Archives/edgar/data/715957/000122520825004863/0001225208-25-004863-index.htm">U.S. Securities and Exchange Commission</a> on Thursday, HAGOOD increased their investment in Dominion Energy by purchasing 3,246 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $177,491.
At Friday morning, Dominion Energy shares are up by 0.49%, trading at $55.27.
<h3>About Dominion Energy</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Dominion Energy's Financial Performance</h3>
Revenue Growth: Dominion Energy's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 12.22%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Utilities sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 50.54%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.75.
</li>
</ul>
Debt Management: Dominion Energy's debt-to-equity ratio surpasses industry norms, standing at 1.67. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 21.24 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 3.11, Dominion Energy's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Dominion Energy's EV/EBITDA ratio stands at 12.94, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
</li>
</ul>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Transaction Codes To Focus On</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bullish Move: MAYBANK HAGOOD Shows Confidence, Acquires $177K In Dominion Energy Stock

Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.
Analysts estimate that Sally Beauty Holdings will report an earnings per share (EPS) of $0.39. 
Investors in Sally Beauty Holdings are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.00, leading to a 3.13% drop in the share price on the subsequent day.
Here's a look at Sally Beauty Holdings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.43</td>
<td>0.47</td>
<td>0.40</td>
<td>0.40</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.50</td>
<td>0.45</td>
<td>0.35</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746802938_0.png" alt="eps graph" />
<h3>Market Performance of Sally Beauty Holdings's Stock</h3>
Shares of Sally Beauty Holdings were trading at $8.35 as of May 08. Over the last 52-week period, shares are down 25.76%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Insights Shared by Analysts on Sally Beauty Holdings</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Sally Beauty Holdings.
The consensus rating for Sally Beauty Holdings is Neutral, derived from 1 analyst ratings. An average one-year price target of $10.5 implies a potential 25.75% upside.
<h3>Understanding Analyst Ratings Among Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Petco Health and Wellness, Build-A-Bear Workshop and MarineMax, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Petco Health and Wellness, with an average 1-year price target of $3.66, suggesting a potential 56.17% downside.</li>
<li>Analysts currently favor an Buy trajectory for Build-A-Bear Workshop, with an average 1-year price target of $56.67, suggesting a potential 578.68% upside.</li>
<li>Analysts currently favor an Buy trajectory for MarineMax, with an average 1-year price target of $26.0, suggesting a potential 211.38% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary provides a snapshot of key metrics for Petco Health and Wellness, Build-A-Bear Workshop and MarineMax, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sally Beauty Holdings</td>
<td>Neutral</td>
<td>0.71%</td>
<td>$476.84M</td>
<td>9.50%</td>
</tr>
<tr>
<td>Petco Health and Wellness</td>
<td>Neutral</td>
<td>-7.31%</td>
<td>$589.26M</td>
<td>-1.24%</td>
</tr>
<tr>
<td>Build-A-Bear Workshop</td>
<td>Buy</td>
<td>0.78%</td>
<td>$85.14M</td>
<td>16.20%</td>
</tr>
<tr>
<td>MarineMax</td>
<td>Buy</td>
<td>8.34%</td>
<td>$189.51M</td>
<td>0.33%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Sally Beauty Holdings ranks in the middle for consensus rating. It is at the bottom for revenue growth. It is at the top for gross profit. It is at the top for return on equity.
<h3>Delving into Sally Beauty Holdings's Background</h3>
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
<h3>Sally Beauty Holdings: Delving into Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Sally Beauty Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.71% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Sally Beauty Holdings's net margin is impressive, surpassing industry averages. With a net margin of 6.51%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Sally Beauty Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 9.5%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.22%, the company showcases effective utilization of assets.
Debt Management: Sally Beauty Holdings's debt-to-equity ratio surpasses industry norms, standing at 2.36. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<a href="https://www.benzinga.com/quote/SBH/earnings">To track all earnings releases for Sally Beauty Holdings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Sally Beauty Holdings's Earnings

Disclosed in the latest SEC filing, a significant insider purchase on May 8, involves Mark Kington, Board Member at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>).
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004864//Archives/edgar/data/715957/000122520825004864/0001225208-25-004864-index.htm">U.S. Securities and Exchange Commission</a> on Thursday unveiled that Kington made a notable purchase of 5,761 shares of Dominion Energy, valuing at $315,011.
The latest update on Friday morning shows Dominion Energy shares up by 0.49%, trading at $55.27.
<h3>All You Need to Know About Dominion Energy</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>A Deep Dive into Dominion Energy's Financials</h3>
Revenue Growth: Dominion Energy displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 12.22%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Utilities sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: With a high gross margin of 50.54%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS reflects a decline, falling below the industry average with a current EPS of 0.75.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.67, caution is advised due to increased financial risk.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 21.24, Dominion Energy's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 3.11 is above industry norms, reflecting an elevated valuation for Dominion Energy's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 12.94 is above the industry average, suggesting that the market values the company more highly for each unit of EBITDA. This could be attributed to factors such as strong growth prospects or superior operational efficiency.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Move: Mark Kington Invests $315K In Dominion Energy Stock

UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) is preparing to release its quarterly earnings on Monday, 2025-05-12. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect UroGen Pharma to report an earnings per share (EPS) of $-0.80.
UroGen Pharma bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.08, leading to a 9.07% increase in the share price the following trading session.
Here's a look at UroGen Pharma's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.72</td>
<td>-0.82</td>
<td>-0.84</td>
<td>-0.87</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.80</td>
<td>-0.55</td>
<td>-0.91</td>
<td>-0.97</td>
</tr>
<tr>
<td>Price Change %</td>
<td>9.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746802929_0.png" alt="eps graph" />
<h3>Performance of UroGen Pharma Shares</h3>
Shares of UroGen Pharma were trading at $10.67 as of May 08. Over the last 52-week period, shares are down 19.43%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/URGN/earnings">To track all earnings releases for UroGen Pharma visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

URGN

A Look at UroGen Pharma's Upcoming Earnings Report

Kristin Lovejoy, Board Member at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>), reported an insider buy on May 8, according to a new SEC filing. 
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004865//Archives/edgar/data/715957/000122520825004865/0001225208-25-004865-index.htm">U.S. Securities and Exchange Commission</a> on Thursday, Lovejoy increased their investment in Dominion Energy by purchasing 5,395 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $294,998.
Dominion Energy shares are trading up 0.49% at $55.27 at the time of this writing on Friday morning.
<h3>Discovering Dominion Energy: A Closer Look</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Understanding the Numbers: Dominion Energy's Finances</h3>
Positive Revenue Trend: Examining Dominion Energy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 12.22% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Utilities sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 50.54%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.75.
</li>
</ul>
Debt Management: Dominion Energy's debt-to-equity ratio surpasses industry norms, standing at 1.67. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: Dominion Energy's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 21.24.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 3.11 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 12.94, Dominion Energy demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Cracking Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Positive Signal: Kristin Lovejoy Shows Faith, Buying $294K In Dominion Energy Stock

Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.
Analysts estimate that Maravai LifeSciences will report an earnings per share (EPS) of $-0.07. 
Investors in Maravai LifeSciences are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings History Snapshot</h3>
Last quarter the company missed EPS by $0.02, which was followed by a 5.81% drop in the share price the next day.
Here's a look at Maravai LifeSciences's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.04</td>
<td>-0.01</td>
<td>0</td>
<td>-0.03</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.06</td>
<td>-0.02</td>
<td>0</td>
<td>-0.02</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>-35.0%</td>
<td>-7.000000000000001%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746802923_0.png" alt="eps graph" />
<h3>Maravai LifeSciences Share Price Analysis</h3>
Shares of Maravai LifeSciences were trading at $2.07 as of May 08. Over the last 52-week period, shares are down 80.58%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Insights Shared by Analysts on Maravai LifeSciences</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Maravai LifeSciences.
Analysts have given Maravai LifeSciences a total of 4 ratings, with the consensus rating being Neutral. The average one-year price target is $4.62, indicating a potential 123.19% upside.
<h3>Comparing Ratings with Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of MaxCyte, CryoPort and Pacific Biosciences, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for MaxCyte, with an average 1-year price target of $9.0, suggesting a potential 334.78% upside.</li>
<li>Analysts currently favor an Buy trajectory for CryoPort, with an average 1-year price target of $10.82, suggesting a potential 422.71% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Pacific Biosciences, with an average 1-year price target of $2.25, suggesting a potential 8.7% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary provides a snapshot of key metrics for MaxCyte, CryoPort and Pacific Biosciences, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Maravai LifeSciences</td>
<td>Neutral</td>
<td>-23.92%</td>
<td>$18.96M</td>
<td>-7.80%</td>
</tr>
<tr>
<td>MaxCyte</td>
<td>Buy</td>
<td>-44.51%</td>
<td>$6.41M</td>
<td>-5.05%</td>
</tr>
<tr>
<td>CryoPort</td>
<td>Buy</td>
<td>-31.06%</td>
<td>$27.28M</td>
<td>-3.65%</td>
</tr>
<tr>
<td>Pacific Biosciences</td>
<td>Outperform</td>
<td>-32.79%</td>
<td>$10.06M</td>
<td>0.49%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Maravai LifeSciences ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity. The consensus rating for Maravai LifeSciences is Neutral, which is better than some peers.
<h3>Get to Know Maravai LifeSciences Better</h3>
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
<h3>Understanding the Numbers: Maravai LifeSciences's Finances</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Negative Revenue Trend: Examining Maravai LifeSciences's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -23.92% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Maravai LifeSciences's net margin is impressive, surpassing industry averages. With a net margin of -46.35%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Maravai LifeSciences's ROE stands out, surpassing industry averages. With an impressive ROE of -7.8%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Maravai LifeSciences's ROA excels beyond industry benchmarks, reaching -2.29%. This signifies efficient management of assets and strong financial health.
Debt Management: Maravai LifeSciences's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.16.
<a href="https://www.benzinga.com/quote/MRVI/earnings">To track all earnings releases for Maravai LifeSciences visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MRVI

Insights Ahead: Maravai LifeSciences's Quarterly Earnings

In a recent SEC filing, it was revealed that JOSEPH RIGBY, Director at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>), made a noteworthy insider purchase on May 8,.
What Happened: RIGBY's recent purchase of 3,767 shares of Dominion Energy, disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004866//Archives/edgar/data/715957/000122520825004866/0001225208-25-004866-index.htm">U.S. Securities and Exchange Commission</a> on Thursday, reflects confidence in the company's potential. The total transaction value is $205,979.
The latest update on Friday morning shows Dominion Energy shares up by 0.49%, trading at $55.27.
<h3>About Dominion Energy</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Unraveling the Financial Story of Dominion Energy</h3>
Revenue Growth: Dominion Energy's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 12.22%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Utilities sector, the company excelled with a growth rate higher than the average among peers.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 50.54%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS reflects a decline, falling below the industry average with a current EPS of 0.75.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.67, Dominion Energy faces challenges in effectively managing its debt levels, indicating potential financial strain.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: Dominion Energy's current Price to Earnings (P/E) ratio of 21.24 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 3.11 is above industry norms, reflecting an elevated valuation for Dominion Energy's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Dominion Energy's EV/EBITDA ratio, surpassing industry averages at 12.94, positions it with an above-average valuation in the market.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Cracking Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Major Purchase Alert: JOSEPH RIGBY Invests $205K In Dominion Energy Stock

It was revealed in a recent SEC filing that Pamela Royal, Board Member at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) made a noteworthy insider purchase on May 8,.
What Happened: In a Form 4 filing on Thursday with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004867//Archives/edgar/data/715957/000122520825004867/0001225208-25-004867-index.htm">U.S. Securities and Exchange Commission</a>, it was disclosed that Royal bought 3,246 shares of Dominion Energy, amounting to a total of $177,491.
During Friday's morning session, Dominion Energy shares up by 0.49%, currently priced at $55.27.
<h3>Unveiling the Story Behind Dominion Energy</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Financial Milestones: Dominion Energy's Journey</h3>
Revenue Growth: Over the 3 months period, Dominion Energy showcased positive performance, achieving a revenue growth rate of 12.22% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Utilities sector, the company excelled with a growth rate higher than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 50.54%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Dominion Energy exhibits below-average bottom-line performance with a current EPS of 0.75.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.67, Dominion Energy faces challenges in effectively managing its debt levels, indicating potential financial strain.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Dominion Energy's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 21.24.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 3.11 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Dominion Energy's EV/EBITDA ratio of 12.94 exceeds industry averages, indicating a premium valuation in the market
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Relevance of Insider Transactions</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Pamela Royal's Recent Buy: Acquires $177K In Dominion Energy Stock

A significant insider buy by Allen Vanessa Sutherland, Board Member at Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>), was executed on May 8, and reported in the recent SEC filing.
What Happened: Sutherland's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000715957/000122520825004868//Archives/edgar/data/715957/000122520825004868/0001225208-25-004868-index.htm">U.S. Securities and Exchange Commission</a> on Thursday, involves purchasing 5,395 shares of Dominion Energy. The total transaction value is $294,998.
At Friday morning, Dominion Energy shares are up by 0.49%, trading at $55.27.
<h3>Discovering Dominion Energy: A Closer Look</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Breaking Down Dominion Energy's Financial Performance</h3>
Revenue Growth: Dominion Energy's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 12.22%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Utilities sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 50.54%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): Dominion Energy's EPS reflects a decline, falling below the industry average with a current EPS of 0.75.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.67, caution is advised due to increased financial risk.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: Dominion Energy's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 21.24.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 3.11 is above industry norms, reflecting an elevated valuation for Dominion Energy's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 12.94, Dominion Energy demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes Worth Your Attention</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000715957">Check Out The Full List Of Dominion Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Portman Ridge Finance

Portman Ridge Finance (PTMN) Opzioni

Portman Ridge Finance (NASDAQ:PTMN) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO